Globally, the burden of ENT disease is great. Disabling hearing loss (DHL) for example, is reported to affect half a billion people worldwide. The majority of afflicted individuals live in lower and middle-income countries (LMIC) [1]. This article, a collaboration...
6 January 2023
| Christopher Prescott (Prof), Racheal Hapunda, Clemence Chidziva, Wakisa Mulwafu (Prof)
|
ENTA - Audiology - Adult
In the last issue of ENT & Audiology News, we heard from retired Professor Christopher Prescott on the challenges faced and progress made made locally to address the inequity and inequality of access to ENT and allied health professional services...
Normally my objective for this column is to highlight an innovation that is already fully realised and on the market. Sometimes it can be fun instead to look forward to what innovations are coming down the pipeline. With that in...
Dr Helen Bevan has been a leader of large scale change in the English National Health Service (NHS) for more than 20 years and was recently recognised as one of the 60 most influential people in the history of the...
Patients planned for chemoradiation to the head and neck are usually advised to expect some pain and soreness during their treatment and that pain relief will be offered as and when it is required. Uncontrolled pain and mucositis affect oral...
Total or near total defects of the lower lip may result from trauma, cancer ablation or congenital causes. Defects usually involve the full thickness and include skin, muscle and mucosa. There are a number of techniques for the one stage...
Having enjoyed yourself at so many meetings, it may strike you or be suggested to you by ‘friends’, that it would be a good idea to organise an international conference. Think of the kudos, the fame, the financial gain for...
One of the most inspiring stories in this issue comes from our very own Shahed Quraishi, OBE. His first mentor in the UK, Pat Bradley, spoke with him about his fascinating journey. Professor M Shahed Quraishi, OBE. Shahed, by way...
The authors retrospectively reviewed the duration of symptom control after intratympanic dexamethasone (IT) injections in 27 patients with Meniere’s disease (MD) over a six-year period. The patients received two IT injections of 3.3mg/ml of dexamethasone one-to-two weeks apart. Eleven patients...
Device activation after cochlear implant surgery was typically performed after wound healing, and varies anytime from three to four weeks after surgery. Nowadays, activation is performed as early as two to three days after surgery. The authors evaluated the effect...
This interesting review article summarises the status as well as future prospects of organoid technology in our field. Organoids are a mass of cells which are typically cultured in vitro with 3D technology. They simulate miniature tissues and organs and...
This prospective longitudinal study evaluated vestibular function inpatients with idiopathic sudden sensorineural hearing loss (ISSHL) using caloric and video head impulse tests. All patients were admitted for treatment of their ISSHL and divided into two cohorts depending on presence or...